Vitamin B6 (measured as pyridoxal 5'-phosphate, the active form) is an essential cofactor in over 100 enzyme reactions including neurotransmitter synthesis, homocysteine metabolism, and red blood cell formation.
B6 deficiency drives elevated homocysteine, mood disturbances, and peripheral neuropathy. Excess supplementation (above 100 mg/day chronically) can paradoxically cause neuropathy. The active P5P form is the most clinically meaningful measurement.
Optimal Vitamin B6: 10-30 ng/mL.
Typically re-tested every 12 weeks.
Vitamin B6 is a water-soluble B vitamin that circulates as a family of related compounds and acts in tissues as pyridoxal 5'-phosphate (PLP), the coenzyme form most laboratories measure.
The vitamin exists as six vitamers, pyridoxine, pyridoxal and pyridoxamine plus their phosphorylated versions. Food and supplements deliver mostly the non-phosphorylated forms, which are absorbed in the small intestine, carried to the liver and converted there into PLP. PLP then travels in plasma bound largely to albumin and is taken up by tissues, where it attaches to enzymes and does the actual chemical work.
That work is unusually broad. PLP serves as the cofactor for more than 100 distinct enzyme reactions, which is why no single symptom or system defines B6 status[1]. Those reactions include transamination, the shuffling of amino groups between amino acids that liver enzymes such as ALT and AST perform; decarboxylation steps that generate serotonin, dopamine and GABA; glycogen phosphorylase, which releases glucose from stored glycogen; the first committed step of haem synthesis for red blood cells; and transsulfuration, the pathway that converts homocysteine into cystathionine and onward to cysteine.
PLP also sits at the centre of tryptophan metabolism. Several enzymes in the kynurenine pathway depend on it, and this chemistry is shared with gut bacteria, which run their own PLP-dependent tryptophan reactions[2]. That overlap matters for testing, because the ratios between tryptophan breakdown products can be used as functional indicators of how much usable B6 the tissues actually have, rather than how much is floating in plasma[3]. Research in both healthy adults and cardiovascular patient cohorts suggests these catabolite ratios track B6 status closely enough to complement a direct plasma measurement[4].
It matters because B6 sits upstream of several processes that accumulate consequences slowly, including homocysteine clearance, neurotransmitter production, red blood cell formation and immune signalling.
The homocysteine link is the most studied. Homocysteine is an amino acid intermediate that is either recycled back to methionine, a step needing B12 and folate, or disposed of through transsulfuration, a step needing PLP. When any of those inputs run short, homocysteine tends to rise. A randomised controlled feeding study found that dietary patterns alone changed serum homocysteine, which shows how responsive this marker is to what reaches the plate rather than to genetics alone[5]. Supplementation research points the same way, with one trial reporting that complex multivitamin supplementation improved homocysteine alongside resistance of LDL cholesterol to oxidation[6]. These findings are associations and short-term biochemical effects, not a promise about future cardiovascular events.
The second thread is inflammation and the kynurenine pathway. Plasma PLP falls during inflammatory states even when intake has not changed, and the tryptophan catabolites downstream of PLP-dependent enzymes shift at the same time. In the Nor-COAST cohort, neopterin, kynurenine metabolites and indexes related to vitamin B6 were associated with post-stroke cognitive impairment, which studies indicate reflects the tangle of inflammation, tryptophan handling and B6 status rather than B6 acting alone[7].
The third is everyday physiology. Because PLP is required for haem synthesis, poor B6 status can contribute to anaemia that looks microcytic on a blood count. Because PLP enzymes make monoamine neurotransmitters, sleep, mood and stress tolerance are plausibly sensitive to status, although in people this is less settled than the link with homocysteine. The practical summary is that a B6 result is most informative as context for other markers, not as a verdict on its own.
Most laboratories report plasma PLP with a typical reference range of 5 to 50 ng/mL, while FitScript's optimal range is narrower at 10 to 30 ng/mL.
| Measure | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Plasma pyridoxal 5'-phosphate (PLP) | 5 to 50 ng/mL | 10 to 30 ng/mL |
Reference ranges vary by laboratory, assay method, age and sex, so always read your result against the range printed on your own report. No separate age-banded or sex-split optimal ranges are published here, because none are supplied for this marker.
The optimal range is an optimization target, not a diagnostic cut-off. A value inside the standard reference range but outside the optimal range is not a disease finding. It is a prompt to look at the pattern, including recent supplement use, inflammatory markers and the rest of the one-carbon panel. A value well outside the standard range in either direction is worth discussing with a clinician, and a markedly abnormal result alongside new symptoms is worth discussing promptly.
A high plasma PLP almost always reflects intake rather than illness, most commonly supplements, and in a smaller number of cases it reflects an enzyme problem that slows PLP breakdown.
People with persistently high intakes sometimes report tingling, numbness, burning or pins and needles in the hands and feet, clumsiness or unsteady walking, and occasionally skin sensitivity to sunlight or nausea. The sensory nerve picture is the one described most often in reviews of B6 excess, and it is linked to prolonged high supplemental intake rather than to food sources[1].
The common causes are mundane. B-complex and multivitamin products, standalone B6 products, energy drinks, fortified foods and some bodybuilding or recovery formulas stack up quickly, and a recent dose taken hours before a blood draw can lift plasma PLP sharply. A 2026 review of elite athletes examined the potential implications of high B6 intakes in that population specifically, where fortified products and multiple supplements overlap[8].
There is one pattern worth knowing. Tissue-nonspecific alkaline phosphatase is the enzyme that removes the phosphate from PLP so the vitamin can enter cells. When that enzyme works poorly, as in hypophosphatasia, plasma PLP accumulates while serum alkaline phosphatase reads low, and laboratories regard that combination as a biochemical hallmark of the condition[9]. Reviews of hypophosphatasia describe the same substrate accumulation alongside skeletal and dental features[10]. A single high PLP with a normal alkaline phosphatase does not point there.
Over the long term, the concern with a sustained high result is sensory neuropathy, which reports describe as typically improving after intake stops, though recovery is not uniform. Do not ignore a high result, and do not change prescribed medication on your own. Bring it to a clinician along with a list of everything you take.
A low plasma PLP suggests that circulating usable B6 is depleted, which can come from low intake, poor absorption, increased demand, active inflammation or interference from medication.
Symptoms people report with poor status are nonspecific and overlap with many other things. They include fatigue and low mood, irritability, cracking at the corners of the mouth, a sore or smooth tongue, a greasy scaly rash around the nose and eyebrows, and in marked deficiency anaemia or, rarely, seizures. None of these confirm anything on their own, and plenty of people with a low result feel fine.
Common causes include diets low in protein foods and whole grains, heavy alcohol use, malabsorptive conditions and coeliac or inflammatory bowel disease, pregnancy, and kidney disease or dialysis. Inflammation is the trap. Plasma PLP drops during inflammatory and infectious states as part of the redistribution that accompanies an acute phase response, so a low value drawn during illness may understate true stores. Functional markers built from the ratios of kynurenine pathway products offer a second view of B6 status alongside plasma PLP[3].
Over time, low status is associated with higher homocysteine and with altered kynurenine metabolism. In one stroke cohort, kynurenine metabolites and B6-related indexes were associated with post-stroke cognitive impairment[7]. This is association rather than cause, and correcting a number is not the same as changing an outcome. The useful next step after a low result is a conversation with a clinician about intake, absorption, medications and whether inflammatory markers should be checked at the same time.
Timing, inflammation, medications and sample handling can all move a plasma PLP value without any real change in your underlying nutrition.
Testing conditions come first. PLP is light sensitive, so tubes that sit exposed or are processed slowly can read lower than reality. Supplement timing matters more than almost anything else, because a dose taken the day before a draw can push a value high; most people get the cleanest picture by testing before the day's supplements and by noting on the requisition what they take. Fasting is not strictly required for this marker, though it is often convenient since B6 is usually drawn with a broader panel. Albumin affects transport, and alkaline phosphatase affects clearance, so both are worth reading on the same report.
Medications and medical conditions form the second group. Several drugs are long recognised to interfere with B6 metabolism, including isoniazid, which binds pyridoxal directly, and hydralazine and penicillamine, which act through similar chemistry. Dopaminergic therapy is another example of how closely these pathways interlock, since research in Parkinson's disease found that L-dopa raised plasma homocysteine in a way that related to B vitamin status[11]. Downstream markers also respond to inputs that have nothing to do with B6, which a randomised controlled study in people receiving haemodialysis illustrated when N-acetylcysteine lowered plasma total homocysteine[12]. None of this is a reason to start or stop a medicine. A licensed provider evaluates whether any prescription change is appropriate for you.
Habits form the third group. Alcohol intake, very high protein loads, pregnancy, smoking and heavy training volume all shift demand or turnover. Gut microbes add another variable, since bacterial PLP-dependent enzymes participate in the same tryptophan chemistry your own cells run[2].
FitScript does not currently test vitamin B6 in a panel, so this marker is not part of the 150+ biomarkers tested per year within the membership.
If you already have a plasma PLP result from another laboratory, you can upload your existing labs so that Atlas, FitScript's AI health advisor, reads it alongside the markers that are measured, including the one-carbon and red blood cell markers that give a B6 value its meaning. Atlas turns that combined picture into your FitScript, the personalised output written from your own biology, and flags patterns that are worth raising with a clinician rather than returning a verdict on a single number.
Any prescription therapy or clinician-gated intervention discussed afterwards is evaluated by a licensed provider who reviews your history and results first. No article, and no algorithm, decides that. This page is educational and is not medical advice. Discuss your results and any treatment decision with a clinician or licensed provider who can see your full history.
B6 is best read with the markers that share its pathways, which means the one-carbon group first and the red blood cell group second.
Homocysteine is the closest functional partner, because PLP drives the transsulfuration route that clears it. A controlled feeding study showed that serum homocysteine changes with dietary pattern[5]. Vitamin B12 and Folate drive the alternative remethylation route, so a raised homocysteine with a normal B6 often points toward one of those two instead. A trial of complex multivitamin supplementation also reported improved homocysteine[6].
Ferritin and Iron matter because PLP is required for the first step of haem synthesis, so anaemia with small red cells can involve iron, B6 or both, and separating them changes what a clinician looks at next. Ferritin also rises with inflammation, which is useful context when a low PLP might be reflecting an acute phase response rather than intake. Vitamin D (25-OH) is worth reading in the same sitting for a different reason, since it belongs to the same general picture of nutrient status, seasonal habits and absorption that tends to move several markers together.
Treat the number as one input, not a conclusion. A plasma PLP inside the typical 5 to 50 ng/mL range tells you the vitamin is present; a value inside FitScript's 10 to 30 ng/mL optimal range suggests there is no obvious shortfall or excess to chase. A high value usually points at supplements and deserves an honest inventory of everything you swallow in a week. A low value deserves a look at intake, absorption, alcohol, medications and whether inflammation was active on the day of the draw. In both directions the next step is the same, which is a conversation with a clinician who can see the whole panel rather than one line of it.
Vitamin B6 works as pyridoxal 5'-phosphate, the cofactor for more than 100 enzyme reactions. Those include amino acid transamination, the production of serotonin, dopamine and GABA, glucose release from glycogen, the first step of haemoglobin synthesis, and the pathway that clears homocysteine. Because its roles are so broad, poor status rarely produces one tidy symptom.
The usual test is plasma pyridoxal 5'-phosphate (PLP), the active coenzyme form, reported in ng/mL. Some laboratories also offer functional indicators derived from tryptophan breakdown products, which behave differently from plasma PLP when inflammation is present and can add context to a borderline value.
A typical laboratory reference range for plasma PLP is 5 to 50 ng/mL, and FitScript's optimal range is 10 to 30 ng/mL. Ranges vary by laboratory, assay, age and sex, so compare your value with the range printed on your own report. The optimal range is an optimization target, not a diagnostic cut-off.
Yes, and a high plasma PLP usually reflects supplement intake rather than illness. Reviews describe sensory nerve symptoms such as tingling or numbness in the hands and feet with prolonged high supplemental intakes. Less commonly, a high PLP with a low alkaline phosphatase is a pattern that laboratories regard as suggestive of hypophosphatasia. Discuss a high result with a clinician rather than acting on it alone.
Low intake, heavy alcohol use, malabsorption, pregnancy, kidney disease or dialysis, and certain medications that interfere with B6 metabolism are all recognised contributors. Active inflammation also lowers plasma PLP independently of intake, so a value drawn during illness may understate true status.
It can. Plasma PLP falls during inflammatory and infectious states as part of the body's acute phase response, which means a low value in that setting may reflect redistribution rather than depletion. Reading B6 alongside an inflammatory marker helps separate the two.
Fasting is not strictly required for this marker, though it is often convenient when B6 is drawn with a broader panel. Supplement timing matters more, since a dose taken shortly before the draw can lift plasma PLP sharply. Testing before the day's supplements and telling the laboratory what you take gives a cleaner picture.
Homocysteine, vitamin B12 and folate share the one-carbon pathways that B6 feeds, so they explain each other. Ferritin and iron matter because B6 is needed for haemoglobin synthesis and anaemia can involve either. Vitamin D rounds out the general nutrient status picture.
FitScript does not currently test vitamin B6 in a panel. If you already have a result from another laboratory, you can upload your existing labs so Atlas, FitScript's AI health advisor, reads it alongside the markers that are measured. Any prescription option is evaluated by a licensed provider.